Article
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.
Antimicrobial agents and chemotherapy - 1 Apr 2004
Mulvey Michael R, Bryce Elizabeth, Boyd David, Ofner-Agostini Marianna, Christianson Sara, Simor Andrew E, Paton Shirley
Abstract excerpt
This report describes a study carried out to gain baseline information on the molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in Canada. A total of 29,323 E. coli and 5,156 Klebsiella sp. isolates were screened at 12 participating sites. Of these, 505 clinically significant, nonrepeat isolates displaying reduced susceptibility to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
